Panta 2
Payments companies reported to CMS as associated with Panta 2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Panta 2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Panta 2
These are the largest totals companies reported as associated with Panta 2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Brodsky | Dallas, TX | Orthopaedic Surgery | $1,309,405.70 |
| Ari Kaz | Chicago, IL | Orthopaedic Surgery | $109,277.23 |
| Lauren Geaney | Farmington, CT | Orthopaedic Surgery | $22,250.36 |
| Elizabeth Hewitt | Grove City, OH | Foot & Ankle Surgery | $16,926.04 |
| Christopher Ritter | Buffalo, NY | Orthopaedic Surgery | $15,465.75 |
| Brian Winters | Cape May Court House, NJ | Orthopaedic Surgery | $14,591.47 |
| Johannes Coetzee | Edina, MN | Foot and Ankle Surgery | $13,963.61 |
| Gabriel Gambardella | Bloomfield, CT | Foot & Ankle Surgery | $13,615.54 |
| Bradley Lamm | West Palm Beach, FL | Foot and Ankle Surgery | $12,412.06 |
| Roy Sanders | Temple Terrace, FL | Orthopaedic Surgery | $8,645.80 |
Prescribed Panta 2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.